Hypertrophy, pathology, and molecular markers of cardiac pathogenesis

Circulation Research

Volumn 82, Issue 7, 1998, Pages 773-778

  Vikstrom, Karen L ^c   Bohlmeyer, Teri ^c   Factor, Stephen M ^a   Leinwand, Leslie A ^b  

^a ALBERT EINSTEIN COLLEGE OF MEDICINE   (United States)

^b UNIVERSITY OF COLORADO   (United States)

^c NONE

Author keywords

Atrial natriuretic factor; Gene expression; Hypertrophy; Pathogenesis

Indexed keywords

ALPHA ACTIN; ATRIAL NATRIURETIC FACTOR; MESSENGER RNA;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DISEASE MARKER; FEMALE; GENE EXPRESSION; HEART MUSCLE FIBROSIS; HYPERTROPHIC CARDIOMYOPATHY; IN SITU HYBRIDIZATION; MOUSE; NONHUMAN; PATHOGENESIS; PRIORITY JOURNAL; SECRETORY GRANULE; TRANSGENIC MOUSE;

EID: 0032550267     PISSN: 00097330     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.RES.82.7.773     Document Type: Article

References (42)

1. Mulvagh ML, Michael LH, Perryman MB, Roberts R, Schneider MD. A hemodynamic load in vivo induces cardiac gene expression of the cellular oncogene, c-myc. Biochem Biophys Res Commun. 1987;147:627-636.
2. Izumo S, Nadal-Ginard B, Mahdavi V. Protooncogene induction and reprogramming of cardiac gene expression produced by pressure overload. Proc Natl Acad Sci U S A. 1988;85:339-343.
3. Villarreal FJ, Dillmann WH. Cardiac hypertrophy-induced changes in mRNA levels for TGF-β1, fibronectin, and collagen. Am J Physiol. 1992;262:H1861-H1866.
4. Calderone A, Takahashi N, Izzo N, Thaik CM, Colucci WS. Pressure- and volume-induced left ventricular hypertrophies are associated with distinct myocyte phenotypes and differential induction of peptide growth factor mRNAs. Circulation. 1995;92:2385-2390.
5. Schwanz K, de la Bastie D, Bouveret P, Oliviero P, Alonso S, Buckingham M. α-Skeletal muscle actin mRNA's accumulate in hypertrophied adult rat hearts. Circ Res. 1986;59:551-555.
6. Boheler KR, Carrier L, de la Bastie D, Allen PD, Komajda M, Mercadier J, Schwartz K. Skeletal actin mRNA increases in the human heart during ontogenic development and is the major isoform of control and failing human hearts. J Clin Invest. 1991;88:323-330.
7. Chassagne C, Wisnewsky C, Schwartz K. Antithetical accumulation of myosin heavy chain but not α-actin mRNA isoforms during early stages of pressure-overload-induced rat cardiac hypertrophy. Circ Res. 1993; 72:857-864.
8. Schiaffino S, Samuel JL, Sassoon D, Lompré AM, Garner I, Marotte F, Buckingham M, Rappaport L, Schwartz K. Nonsynchronous accumulation of α-skeletal actin and β-myosin heavy chain mRNAs during early stages of pressure-overload-induced cardiac hypertrophy demonstrated by in situ hybridization. Circ Res. 1989;64:937-948.
9. Chien KR, Zhu H, Knowlton KU, Miller-Hance W, van-Bilsen M, O'Brien TX, Evans SM. Transcriptional regulation during cardiac growth and development. Annu Rev Physiol. 1993;55:77-95.
10. Fukui K, Iwao H, Nakamura A, Yamamoto A, Tamaki T, Shoji T, Kimura S, Aki Y, Hasui K, Ohkubo H, Nakanishi S, Abe Y. Captopril and hydralazine suppress atrial natriuretic peptide (ANP) gene expression in the ventricles of spontaneously hypertensive rat. Biochem Biophys Res Commun. 1989;160:310-316.
11. Mercadier J, Samuel J, Michel J, Zongazo M, de la Bastie D, Lompré A, Wisnewsky C, Rappaport L, Levy B, Schwartz K. Atrial natriuretic factor gene expression in rat ventricle during experimental hypertension. Am J Physiol. 1989;257:H979-H987.
12. Matsubara H, Yamamoto J, Hirata Y, Mori Y, Oikawa S, Inada M. Changes in atrial natriuretic peptide and its messenger RNA with development and regression of cardiac hypertrophy in renovascular hypertensive rats. Circ Res. 1990;66:176-184.
13. Feldman AM, Ray PE, Silan CM, Mercer JA, Minobe W, Bristow MR. Selective gene expression in failing human heart: quantification of steady-state levels of messenger RNA in endomyocardial biopsies using the polymerase chain reaction. Circulation. 1991;:83:1866-1872.
14. Feldman AM, Weinberg EO, Ray PE, Lorell BH. Selective changes in cardiac gene expression during compensated hypertrophy and the transition to cardiac decompensation in rats with chronic aortic banding. Circ Res. 1993;73:184-192.
15. 2+-ATPase gene. Circ Res. 1992;71:9-17.
16. Boluyt MO, O'Neill L, Meredith AL, Bing OHL, Brooks WW, Conrad CH, Crow MT, Lakatta EG. Alterations in cardiac gene expression during the transition from stable hypertrophy to heart failure: marked upregulation of genes encoding extracellular matrix components. Circ Res. 1994;75:23-32.
17. Rosenzweig A, Seidman CE. Atrial natriuretic factor and related peptide hormones. Annu Rev Biochem. 1991;60:229-255.
18. de Bold AJ, Bruneau BG, Kuroski de Bold ML. Mechanical and neuroendocrine regulation of the endocrine heart. Cardiovasc Res. 1996;31:7-18.
19. de Bold AJ. Atrial natriuretic factor: a hormone produced by the heart. Science. 1985;230:767-770.
20. Gardner DG, Deschepper CF, Ganong WF, Hane S, Fiddes J, Baxter JD, Lewick J. Extra-atrial expression of the gene for atrial natriuretic factor. Proc Natl Acad Sci U S A. 1986;83:6697-6701.
21. Vikstrom KL, Factor SM, Leinwand LA. Mice expressing mutant myosin are a model for hypertrophic cardiomyopathy. Mol Med. 1996;2:556-567.
22. Chomczynski P, Sacchi N. Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Anal Biochem. 1987;162:156-169.
23. Seidman CE, Duby AD, Choi E, Graham RM, Haber E, Homey C, Smith JA, Seidman JG. The structure of rat preproatrial natriuretic factor as defined by a complementary DNA clone. Science. 1984;225:324-326.
24. Piechaczyk M, Blanchurd JM, Marty L, Dani C, Panabieres F, El Sabouty S, Fort P, Jeanteur P. Post-transcriptional regulation of glyceraldehyde-3-phosphate-dehydrogenase gene expression in rat tissue. Nucleic Acids Res. 1984;12:6951-6963.
25. Sassoon DA, Garner I, Buckingham M. Transcripts of α-cardiac and α-skeletal actins are early markers for myogenesis in the mouse embryo. Development. 1988;104:155-164.
26. Sassoon D, Rosenthal N. Detection of messenger RNA by in situ hybridization. Methods Enzymol. 1993;225:384-404.
27. Wilkonson A. A molecular analysis of mouse development from 8 to 10 days post coitum detects changes only in embryonic globin expression. Development. 1987;99:493-500.
28. McDowell EM, Trump BF. Histological fixatives suitable for diagnostic light and electron microscopy. Arch Pathol Lab Med. 1976;100:405-414.
29. Bloch KD, Seidman JG, Naftilan JD, Fallon JT, Seidman CE. Neonatal atria and ventricles secrete atrial natriuretic factor via tissue-specific secretory pathways. Cell. 1986;47:695-702.
30. Ding J, Thibault G, Gutkowska J, Garcia R, Karabatsos T, Jasmin G, Genest J, Cantin M. Cardiac and plasma atrial natriuretic factor in experimental congestive heart failure. Endocrinology. 1987;121:248-257.
31. Katz AM. Mechanisms of disease. N Engl J Med. 1990;322:100-110.
32. Schwartz K, Boheler KR, de la Bastie D, Lompré A, Mercadier J. Switches in cardiac muscle gene expression as a result of pressure and volume overload. Am J Physiol. 1992;262:R364-R369.
33. Yokata N, Bruneau BG, Fernandez BE, Kuroski de Bold ML, Piazza LA, Eid H, de Bold AJ. Dissociation of cardiac hypertrophy, myosin heavy chain isoform expression, and natriuretic peptide production in DOCA-salt rats. Am J Hypertens. 1995;8:301-310.
34. Yoshimine K, Horiuchi M, Suzuki S, Kobayashi K, Abdul JM, Masuda M, Tomomura M, Ogawa Y, Itoh H, Nakao K, Osame M, Sahek T. Altered expression of atrial natriuretic peptide and contractile protein genes in hypertrophied ventricle of JVS mice with systemic carnitine deficiency. J Mol Cell Cardiol. 1997;29:571-578.
35. Sadoshima J, Jahn L, Takahashi T, Kulik TJ, Izumo S. Molecular characterization of the stretch-induced adaptation of cultured cardiac cells. J Biol Chem. 1992;267:10551-10560.
36. Boluyt MO, Long X, Eschenhagen T, Mende U, Schmitz W, Crow MT, Lakatta EG. Isoproterenol infusion induces alterations in expression of hypertrophy-associated genes in rat heart. Am J Physiol. 1995;269:H638-H647.
37. Rozich JD, Barnes MA, Schmid PG, Zile MR, McDermott PJ, Cooper G IV. Load effects on gene expression during cardiac hypertrophy. J Mol Cell Cardiol. 1995;27:485-499.
38. Ogawa T, Linz W, Stevenson M. Bruneau BG, Kuroski ML, Chen JH, Eid H, Schölkens BA, de Bold AJ. Evidence for load-dependent and load-independent determinants of cardiac natriuretic peptide production. Circulation. 1996;93:2059-2067.
39. Rockman H, Ono S, Ross RS, Jones LR, Karimi M, Bhargava V, Ross J Jr, Chien KR. Molecular and physiological alterations in murine ventricular dysfunction. Proc Natl Acad Sci U S A. 1994;91:2694-2698.
40. Maron BJ, Wolfson JK, Epstein SE, Roberts WC. Intramural ('small vessel') coronary artery disease in hypertrophic cardiomyopathy. J Am Coll Cardiol. 1986;8:545-557.
41. Di Nardo P, Minieri M, Carbone A, Maggiano N, Micheletti R, Peruzzi G, Tallarida G. Myocardial expression of atrial natriuretic factor gene in early stages of hamster cardiomyopathy. Mol Cell Biochem. 1993;125:179-192.
42. Takemura G, Fujiwara H, Mukoyama M, Saito Y, Nakao K, Kawamura A, Ishida M, Kida M, Uegaito T, Tanaka M, Matsumori A, Fujiwara T, Imura H, Kawai C. Expression and distribution of atrial natriuretic peptide in human hypertrophic ventricle of hypertensive hearts and hearts with hypertrophic cardiomyopathy. Circulation. 1991;83:181-190.